Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | -376,418 | -199,582 | 264,000 | 647,000 | 287,000 |
| Other Operating Activity | 376,418 | 1,271,391 | -264,000 | -647,000 | -287,000 |
| Operating Cash Flow | $N/A | $1,071,808 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -225,050 | -138,950 | -438,000 | -258,000 | -271,000 |
| Net Acquisitions | N/A | N/A | -4,000 | -9,000 | N/A |
| Purchase Of Investment | -6,158 | -8,842 | -57,000 | -6,000 | -6,000 |
| Sale Of Investment | 56,315 | 41,685 | 7,000 | 17,000 | 63,000 |
| Other Investing Activity | 36,001 | -36,001 | 36,000 | 9,000 | 0 |
| Investing Cash Flow | $-138,892 | $-142,108 | $-456,000 | $-247,000 | $-214,000 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 11,053 | 6,947 | 8,000 | 12,000 | 18,000 |
| Common Stock Repurchased | -286,364 | -240,636 | -279,000 | -353,000 | -1,084,000 |
| Dividend Paid | -760,886 | -526,114 | N/A | -536,000 | -719,000 |
| Other Financing Activity | 1,389,841 | 63,159 | 623,000 | 496,000 | 776,000 |
| Financing Cash Flow | $353,644 | $-696,644 | $352,000 | $-381,000 | $-1,009,000 |
| Exchange Rate Effect | N/A | 49,896 | N/A | N/A | N/A |
| Beginning Cash Position | N/A | 618,327 | N/A | N/A | N/A |
| End Cash Position | 173,000 | 901,279 | -234,000 | 1,000 | -426,000 |
| Net Cash Flow | $-60,057 | $233,057 | $404,000 | $427,000 | $-314,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 1,071,808 | N/A | N/A | N/A |
| Capital Expenditure | -242,155 | -152,845 | -464,000 | -263,000 | -291,000 |
| Free Cash Flow | -242,155 | 918,963 | -464,000 | -263,000 | -291,000 |